Unlearn.AI Revenue and Competitors
Estimated Revenue & Valuation
- Unlearn.AI's estimated annual revenue is currently $23.2M per year.
- Unlearn.AI's estimated revenue per employee is $305,263
- Unlearn.AI's total funding is $135M.
- Unlearn.AI's current valuation is $265M. (March 2023)
Employee Data
- Unlearn.AI has 76 Employees.
- Unlearn.AI grew their employee count by -16% last year.
Unlearn.AI's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Commercial Officer | Reveal Email/Phone |
2 | Head Business Development | Reveal Email/Phone |
3 | Head People | Reveal Email/Phone |
4 | Head Platform | Reveal Email/Phone |
5 | Director, Business Development | Reveal Email/Phone |
6 | Director, Business Development | Reveal Email/Phone |
7 | Director Customer Solutions | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Data Scientist | Reveal Email/Phone |
10 | Engineering Manager | Reveal Email/Phone |
Unlearn.AI Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $63.8M | 187 | 26% | N/A | N/A |
#2 | $22.6M | 142 | 5% | N/A | N/A |
#3 | $0.3M | 2 | -33% | N/A | N/A |
#4 | $9.7M | 39 | -5% | N/A | N/A |
#5 | $1.6M | 18 | -10% | N/A | N/A |
#6 | $4.2M | 28 | -18% | $11.4M | N/A |
#7 | $2M | 20 | -17% | $5.65M | N/A |
#8 | $0.3M | 4 | 0% | N/A | N/A |
#9 | $13.6M | 49 | -16% | N/A | N/A |
#10 | $2.1M | 11 | N/A | N/A | N/A |
What Is Unlearn.AI?
Accelerating clinical trials with AI. It's about time.
keywords:N/A
$135M
Total Funding
76
Number of Employees
$23.2M
Revenue (est)
-16%
Employee Growth %
$265M
Valuation
N/A
Accelerator
Unlearn.AI News
Unlearn works with pharma sponsors, biotech companies, and academic institutions to optimize human clinical trials with TwinRCTs.
Unlearn.AI, a startup developing 'digital twin' technology for clinical trial applications, has raised $60 million in a venture round led by...
Unlearn.AI's Series B round follows a positive European Medicines Agency draft opinion finding that the company's artificial intelligence...
Our goal is to reduce clinical trial timelines as much as possible, while producing robust and reliable evidence - Charles Fisher, Ph.D., founder and CEO of Unlearn.AI LOS ANGELES (PRWEB) October 27, 2021 BioTech Breakthrough, a leading independent market intelligence organization that evaluat ...
Unlearn, a San Francisco, CA-based developer of a machine-learning platform that creates Digital Twins used to populate Intelligent Control Arms in clinical studies, raised an approx. $3m Series A extension funding round. Backers included Eisai, Epic Ventures and Alumni Ventures Group. In Apri ...
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $17.3M | 76 | 1% | N/A |
#2 | $23.2M | 76 | -8% | $34M |
#3 | $11M | 76 | 3% | $3.6M |
#4 | $11M | 76 | N/A | N/A |
#5 | $19.3M | 76 | 43% | N/A |